May 20, 2016
Speaking yesterday at the Financial Times U.S. Healthcare & Life Sciences Summit, Leonard Schleifer, chief executive officer of Regeneron Pharmaceuticals, sharply criticized the results of a report written by Boston-based Institute for Clinical and Economic Review...